Page last updated: 2024-08-23

idarubicin and Multiple Primary Neoplasms

idarubicin has been researched along with Multiple Primary Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coombs, CC; Mathews, SP1
Antoneli, CB; Arias, VE; Chojniak, MM; Novaes, PE; Ribeiro, Kde C; Sakamoto, LH1
Akçali, Z; Boğa, S; DemIrhan, B; Karakuş, S; Sahin, FI; Yilmaz, Z1
Escudier, SM; Estey, EH; Kantarjian, HM1
Casak, S; Chantada, GL; Fandiño, A; Mato, G1
Dunkley, S; Gibson, J; Iland, H; Joshua, D; Li, C1
Bessho, M; Hirashima, K; Kawai, N; Kayano, H; Kusumoto, S; Matsuda, A; Sakata, T; Sugahara, Y; Suzuki, T; Yagasaki, F; Yoshida, K1

Reviews

1 review(s) available for idarubicin and Multiple Primary Neoplasms

ArticleYear
Trilateral retinoblastoma.
    Pediatric blood & cancer, 2007, Volume: 48, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Female; Humans; Idarubicin; Ifosfamide; Male; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neoplastic Syndromes, Hereditary; Pinealoma; Prognosis; Retinoblastoma; Vincristine

2007

Trials

2 trial(s) available for idarubicin and Multiple Primary Neoplasms

ArticleYear
Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
    Leukemia & lymphoma, 1996, Volume: 20, Issue:5-6

    Topics: Adult; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cohort Studies; Cytarabine; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Germinoma; Hemorrhage; Humans; Idarubicin; Incidence; Infarction; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Melanoma; Middle Aged; Myocardial Infarction; Neoplasms, Multiple Primary; Remission Induction; Retrospective Studies; Spleen; Thrombosis; Treatment Outcome; Tretinoin

1996
Phase II window of idarubicin in children with extraocular retinoblastoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:6

    Topics: Antibiotics, Antineoplastic; Bone Marrow Neoplasms; Bone Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Infant; Lymphatic Metastasis; Male; Neoplasms, Multiple Primary; Orbital Neoplasms; Retinoblastoma; Treatment Outcome

1999

Other Studies

4 other study(ies) available for idarubicin and Multiple Primary Neoplasms

ArticleYear
Acute promyelocytic leukemia and chronic lymphocytic leukemia diagnosed concurrently.
    American journal of hematology, 2018, Volume: 93, Issue:4

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Arsenicals; Bone Marrow; Diabetes Mellitus, Type 2; Humans; Idarubicin; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasms, Multiple Primary; Remission Induction; Tretinoin

2018
t(8;16) AML developed subsequent to breast cancer therapy.
    Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Estrogens; Fatal Outcome; Female; Fluorouracil; Humans; Idarubicin; Leukemia, Myelomonocytic, Acute; Mastectomy, Modified Radical; Middle Aged; Neoplasms, Hormone-Dependent; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nitriles; Radiotherapy, Adjuvant; Translocation, Genetic; Triazoles

2006
Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
    Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Lineage; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Clone Cells; Combined Modality Therapy; Diphosphonates; Embryonal Carcinoma Stem Cells; Female; Gene Rearrangement, B-Lymphocyte, Light Chain; Humans; Idarubicin; Immunoglobulin kappa-Chains; Leukemia, Promyelocytic, Acute; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Proteins; Neoplasms, Multiple Primary; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Osteolysis; Pamidronate; Prednisone; Remission Induction; Translocation, Genetic; Tretinoin

1999
[CD7(+) acute myeloid leukemia (M0) associated with a mediastinal bulky mass lesion].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2001, Volume: 42, Issue:8

    Topics: Adult; Antigens, CD7; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diagnosis, Differential; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Neoplasms, Multiple Primary; Remission Induction

2001